Journal of Medical Genetics · 1998 · 17 citations · 21 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsPediatric GeneticsAllele NomenclatureCystic FibrosisFibrosisGenetic DisordersRare Disease GeneticsCftr Gene MutationsCystic Fibrosis GeneticsHeterozygote PhenotypeSubjectsSweat Chloride Testing
Only three mutant cystic fibrosis (CF) alleles have to date been established as conferring a dominant mild effect on affected subjects who are compound heterozygotes. We now add a fourth, P67L, which occurs on about 1.4% of Scottish CF chromosomes. Among 13 patients (12 unrelated) with this allele, the average age at diagnosis was 22.5 +/- 11.3 years. None of the cases had consistently raised sweat chloride concentrations, the average value being 57 +/- 9 mmol/l; 77% of the patients were pancreatic sufficient. When compared to three other established mild CF alleles, R117H, A455E, and 3849 + 10kb C-T, a compound heterozygote for P67L has minimal disease and clinical suspicions are unlikely to be confirmed other than by DNA typing.
21
Batsheva Kerem, Julian Zielenski, D. Markiewicz et al. · Proceedings of the National Academy of Sciences · 1990 · 424 citations
Congenital Bilateral Absence of the Vas Deferens
Arturo Anguiano · JAMA · 1992 · 372 citations
Detection of over 98% cystic fibrosis mutations in a Celtic population
Claude Férec, M.‐P. Audrézet, Bernard Mercier et al. · Nature Genetics · 1992 · 184 citations